v3.23.3
Consolidated Balance Sheets - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Current Assets    
Cash and cash equivalents $ 145,618 $ 235,311
Accounts receivable 45,000
Marketable securities 178,702 148,808
Total Current Assets 324,320 429,119
Total Assets 324,320 429,119
Current Liabilities    
Accounts payable and accrued expenses 1,359,481 1,220,017
Total Current Liabilities 4,249,740 4,110,276
Long Term Liabilities    
Convertible note payable, net of debt discount of $11,340 and $19,845 as of September 30, 2023 and December 31, 2022 488,660 480,155
Total Long-Term Liabilities 488,660 480,155
Total Liabilities 4,738,400 4,590,431
Commitments and Contingencies (Note 8)
Stockholders’ Deficit    
Preferred stock, $0.0001 par value, 50,000,000 shares authorized, none issued and outstanding as of September 30, 2023 and December 31, 2022
Common stock, $0.0001 par value: authorized 500,000,000, 21,674,000 and 21,674,000 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively 2,167 2,167
Additional paid-in capital 810,048 810,048
Accumulated deficit (5,226,295) (4,973,527)
Total Stockholders’ Deficit (4,414,080) (4,161,312)
Total Liabilities and Stockholders’ Deficit 324,320 429,119
Related Party [Member]    
Current Liabilities    
Accounts payable - related party 911,659 911,659
Short -term advances - related party 1,673,558 1,673,558
Convertible notes payable 173,192 173,192
Notes payable - related party - net of debt discount of $0 and $0 as of September 30, 2023 and December 31, 2022 106,850 106,850
Nonrelated Party [Member]    
Current Liabilities    
Convertible notes payable $ 25,000 $ 25,000

Source